Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

Acquired byMacroGenics
Date7/2008

General Information

CategoryBioTech
Phone650-624-2600
Employees
Founded1999

Offices

South San Francisco, USA
One Corporate Drive
South San Francisco, CA, 94080
USA

People

Funding

Tags

Raven Biotechnologies

Raven biotechnologies, Inc., a biotechnology company, focuses on the development of monoclonal antibody therapeutics for treating cancer. Its lead product candidate, RAV12, targets adenocarcinomas and used for the treatment of gastrointestinal, lung, colon, pancreatic, prostate, breast, brain, and ovarian cancer. The company was founded in 1999 and is based in South San Francisco, California. As of July 17, 2008, Raven Biotechnologies, Inc. operates as a subsidiary of MacroGenics, Inc.

Recent Milestones

Videos

Screenshots

Sources

  1. MacroGenics, Inc. (JOBS) Acquires Raven Biotechnologies, Inc. (biospace.com) [edit]
  2. RAVEN BIOTECHNOLOGIES INC. RAISES $48.3 MILLION IN SERIES D FINANCING (freshnews.com) [edit]
Edit This Page
Last Edited 11/23/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy